#EventsAlert Piramal Pharma Solutions will be present at all these events. Don’t miss out on your opportunity to meet our experts at these events and learn more about our offerings across the drug value chain. #GlobalCDMO #Pharma
Piramal Pharma Solutions
Pharmaceutical Manufacturing
Lexington, KY 149,500 followers
About us
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.
- Website
-
http://www.piramalpharmasolutions.com
External link for Piramal Pharma Solutions
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Lexington, KY
- Type
- Public Company
- Specialties
- Contract Development and Manufacturing, Formulation Development, Antibody Drug Conjugation, Off Patent APIs, HPAPI, ADC, Oral Solids, Sterile Injectibles, Discovery Services , Hormonal Drugs, and peptides
Locations
Employees at Piramal Pharma Solutions
-
Frédéric Kahn
A leader with 30+ yrs of experience in the pharmaceuticals sector globally, committed to maximizing customer, employee & community happiness…
-
Paul Defina
Senior Director, Business Development
-
Paul Ege
Project Manager at Piramal Pharma Solutions
-
Charles Stankovic
Manager Regulatory Affairs at Ash Stevens LLC, a subsidiary of Piramal Pharma Solutions
Updates
-
We are LIVE at TIDES USA and talking Peptides! Stop by our booth no 718 and talk to our team of experts about your outsourcing requirements. Don’t miss out! Matteo Villain, Pharm.D., Brian Heinz, Tseday Siyoum, Paul Defina #TIDESUSA #PPS #Pharma #Peptides
-
-
The synthesis and development of PROTACs have recently gained significant attention due to their mode of action in target protein degradation. Piramal Discovery Services boasts expertise in PROTAC synthesis for targeted protein degradation and integrated drug discovery. PROTAC synthesis is integral to our comprehensive drug discovery services at Piramal Discovery Services, Ahmedabad. To know more, reach out to us at: contact.us@piramal.com #DiscoveryServices #DiscoveryAtPDS #PiramalDiscoveryServices #InVitroBiology #ADME #Chemistry
-
Meet Matteo Villain, Pharm.D. – a key member of our Science Collective is at TIDES USA. With 20 years of experience in CDMO roles, he brings expertise in peptide API development, GMP commercial manufacturing, CMC development, and API lifecycle management to our organization. Come and meet Matteo! 🗓️: 14th-17th May 📍: Hynes Convention Center, Boston Booth no. 718 #TIDESUSA #PPS #Pharma
-
Are you in Boston yet? Connect with our experts Matteo Villain, Pharm.D., Brian Heinz, Tseday Siyoum and Paul Defina, at Tides USA to look at our discovery solutions and site expansions. 🗓️: 14th-17th May 📍: Hynes Convention Center, Boston Booth no. 718 #TIDESUSA #PPS #Pharma
-
-
Block your calendar because Piramal Pharma Solutions is here! Meet our experts Stuart Needleman, Kelly Stetter, Viacheslav Katin, Brian Heinz, Jason Dwinell, Thomas B. Gold (Brad), Matteo Villain, Pharm.D., and Atin Tomar. Learn more about our offerings as a global CDMO and why we are a trusted partner to companies worldwide. 🗓️: 3rd-6th June 📍: San Diego Convention Center, California Booth no. 4613 #BIO #BIO2024 #PPS #Pharma
-
-
Piramal Pharma Solutions reposted this
Piramal Pharma Limited’s adjusted Net Profit After Tax more than doubled in Q4 FY24 at INR 132 crores compared to INR 50 crores in Q4 FY23. View PPL’s Q4 and FY2024 press release here https://lnkd.in/dgEq7Z98
-
-
Matteo Villain, Pharm.D., our VP and Global Peptides Technical Lead, will be presenting a workshop entitled “Analytical Strategies for Therapeutic Peptides” on Tuesday, May 14th at 9am. It’s your opportunity to keep up to date on current peptide analytics. Don’t miss it! Register using the code P24TIDESKR for 10% off, or click here: https://lnkd.in/g5rMs7K4. Book a meeting with us today! 🗓️: 14th May 📍: Hynes Convention Center, Boston Time: 9 a.m. #TIDESUSA #PPS #Pharma
-